Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays

Abstract There is a plethora of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) serological tests based either on nucleocapsid phosphoprotein (N), S1-subunit of spike glycoprotein (S1) or receptor binding domain (RBD). Although these single-antigen based tests demonstrate high clinical...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Christos Fotis, Nikolaos Meimetis, Nikos Tsolakos, Marianna Politou, Karolina Akinosoglou, Vaia Pliaka, Angeliki Minia, Evangelos Terpos, Ioannis P. Trougakos, Andreas Mentis, Markos Marangos, George Panayiotakopoulos, Meletios A. Dimopoulos, Charalampos Gogos, Alexandros Spyridonidis, Leonidas G. Alexopoulos
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/858a40ad7d234e85a90d69d2e74774df
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/858a40ad7d234e85a90d69d2e74774df

Documents similaires